| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2020 | Gál Z, Gézsi A, Molnár V, Nagy A, Kiss A, Sultész M, Csoma Z, Tamási L, Gálffy G, Bálint BL, Póliska S, Szalai C. Corrigendum: Investigation of the Possible Role of Tie2 Pathway and Gene in Asthma and Allergic Conjunctivitis. Frontiers in Genetics. 11: 702. PMID 32754197 DOI: 10.3389/Fgene.2020.00702 | 0.446 | |||
| 2020 | Csoma Z, Gál Z, Gézsi A, Herjavecz I, Szalai C. Prevalence and characterization of severe asthma in Hungary. Scientific Reports. 10: 9274. PMID 32518278 DOI: 10.1038/S41598-020-66445-4 | 0.46 | |||
| 2020 | Gál Z, Gézsi A, Molnár V, Nagy A, Kiss A, Sultész M, Csoma Z, Tamási L, Gálffy G, Bálint BL, Póliska S, Szalai C. Investigation of the Possible Role of Tie2 Pathway and Gene in Asthma and Allergic Conjunctivitis. Frontiers in Genetics. 11: 128. PMID 32180797 DOI: 10.3389/Fgene.2020.00128 | 0.516 | |||
| 2020 | Gál Z, Gézsi A, Pállinger É, Visnovitz T, Nagy A, Kiss A, Sultész M, Csoma Z, Tamási L, Gálffy G, Szalai C. Plasma neutrophil extracellular trap level is modified by disease severity and inhaled corticosteroids in chronic inflammatory lung diseases. Scientific Reports. 10: 4320. PMID 32152402 DOI: 10.1038/S41598-020-61253-2 | 0.4 | |||
| 2018 | Fodor LE, Gézsi A, Gál Z, Nagy A, Kiss A, Bikov A, Szalai C. Variation in the TEK gene is not associated with asthma but with allergic conjunctivitis. International Journal of Immunogenetics. PMID 29667338 DOI: 10.1111/Iji.12365 | 0.516 | |||
| 2017 | Farzan N, Vijverberg SJ, Andiappan AK, Arianto L, Berce V, Blanca-López N, Bisgaard H, Bønnelykke K, Burchard EG, Campo P, Canino G, Carleton B, Celedón JC, Chew FT, Chiang WC, ... ... Szalai C, et al. Rationale and design of the multiethnic Pharmacogenomics in Childhood Asthma consortium. Pharmacogenomics. PMID 28639505 DOI: 10.2217/Pgs-2017-0035 | 0.451 | |||
| 2017 | Kutszegi N, Yang X, Gézsi A, Schermann G, Erdélyi DJ, Semsei ÁF, Gábor KM, Sági JC, Kovács GT, Falus A, Zhang H, Szalai C. HLA-DRB1*07:01-HLA-DQA1*02:01-HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia. Haematologica. PMID 28596278 DOI: 10.3324/Haematol.2017.168211 | 0.321 | |||
| 2017 | Fodor LE, Gézsi A, Ungvári L, Semsei AF, Gál Z, Nagy A, Gálffy G, Tamási L, Kiss A, Antal P, Szalai C. Investigation of the Possible Role of the Hippo/YAP1 Pathway in Asthma and Allergy. Allergy, Asthma & Immunology Research. 9: 247-256. PMID 28293931 DOI: 10.4168/Aair.2017.9.3.247 | 0.458 | |||
| 2016 | Hegyi M, Arany A, Semsei AF, Csordas K, Eipel O, Gezsi A, Kutszegi N, Csoka M, Muller J, Erdelyi DJ, Antal P, Szalai C, Kovacs GT. Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma. Oncotarget. PMID 27566582 DOI: 10.18632/Oncotarget.11543 | 0.318 | |||
| 2016 | Farzan N, Vijverberg SJ, Andiappan AK, Blanca-Lopez N, Bønnelykke K, Campo P, Canino G, Carleton B, Celedón JC, Chew FT, Cloutier MM, Daley D, Dijk N, Duijts L, Flores C, ... ... Szalai C, et al. Defining uncontrolled childhood asthma in the global PiCA consortium European Respiratory Journal. 48. DOI: 10.1183/13993003.Congress-2016.Pa4388 | 0.467 | |||
| 2015 | Kutszegi N, Semsei ÁF, Gézsi A, Sági JC, Nagy V, Csordás K, Jakab Z, Lautner-Csorba O, Gábor KM, Kovács GT, Erdélyi DJ, Szalai C. Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity. Plos One. 10: e0140136. PMID 26457809 DOI: 10.1371/Journal.Pone.0140136 | 0.352 | |||
| 2015 | Gabor KM, Schermann G, Lautner-Csorba O, Rarosi F, Erdelyi DJ, Endreffy E, Berek K, Bartyik K, Bereczki C, Szalai C, Semsei AF. Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. 62: 622-8. PMID 25557962 DOI: 10.1002/Pbc.25379 | 0.358 | |||
| 2015 | Gézsi A, Lautner-Csorba O, Erdélyi DJ, Hullám G, Antal P, Semsei ÁF, Kutszegi N, Hegyi M, Csordás K, Kovács G, Szalai C. In interaction with gender a common CYP3A4 polymorphism may influence the survival rate of chemotherapy for childhood acute lymphoblastic leukemia. The Pharmacogenomics Journal. 15: 241-7. PMID 25266680 DOI: 10.1038/Tpj.2014.60 | 0.353 | |||
| 2014 | Temesi G, Virág V, Hadadi E, Ungvári I, Fodor LE, Bikov A, Nagy A, Gálffy G, Tamási L, Horváth I, Kiss A, Hullám G, Gézsi A, Sárközy P, Antal P, ... ... Szalai C, et al. Novel genes in Human Asthma Based on a Mouse Model of Allergic Airway Inflammation and Human Investigations. Allergy, Asthma & Immunology Research. 6: 496-503. PMID 25374748 DOI: 10.4168/Aair.2014.6.6.496 | 0.467 | |||
| 2014 | Csordas K, Lautner-Csorba O, Semsei AF, Harnos A, Hegyi M, Erdelyi DJ, Eipel OT, Szalai C, Kovacs GT. Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia. British Journal of Haematology. 166: 410-20. PMID 24712521 DOI: 10.1111/Bjh.12886 | 0.355 | |||
| 2013 | Lautner-Csorba O, Gézsi A, Erdélyi DJ, Hullám G, Antal P, Semsei ÃF, Kutszegi N, Kovács G, Falus A, Szalai C. Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis. Plos One. 8: e69843. PMID 23940529 DOI: 10.1371/Journal.Pone.0069843 | 0.369 | |||
| 2013 | Weiszhár Z, Bikov A, Gálffy G, Tamási L, Ungvári I, Szalai C, Losonczy G, Horváth I. Elevated complement factor H levels in asthmatic sputa. Journal of Clinical Immunology. 33: 496-505. PMID 23070659 DOI: 10.1007/S10875-012-9807-8 | 0.331 | |||
| 2013 | Csoma Z, Antus B, Barta I, Szalai C, Semsei AF, Herjavecz I. Severe asthma database in Hungary, initial steps Clinical and Translational Allergy. 3. DOI: 10.1186/2045-7022-3-S1-P33 | 0.481 | |||
| 2012 | Lautner-Csorba O, Gézsi A, Semsei AF, Antal P, Erdélyi DJ, Schermann G, Kutszegi N, Csordás K, Hegyi M, Kovács G, Falus A, Szalai C. Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance. Bmc Medical Genomics. 5: 42. PMID 23021489 DOI: 10.1186/1755-8794-5-42 | 0.371 | |||
| 2012 | Pál Z, Antal P, Srivastava SK, Hullám G, Semsei AF, Gál J, Svébis M, Soós G, Szalai C, André S, Gordeeva E, Nagy G, Kaltner H, Bovin NV, Molnár MJ, et al. Non-synonymous single nucleotide polymorphisms in genes for immunoregulatory galectins: association of galectin-8 (F19Y) occurrence with autoimmune diseases in a Caucasian population. Biochimica Et Biophysica Acta. 1820: 1512-8. PMID 22683700 DOI: 10.1016/J.Bbagen.2012.05.015 | 0.327 | |||
| 2012 | Simon T, Semsei AF, Ungvári I, Hadadi E, Virág V, Nagy A, Vangor MS, László V, Szalai C, Falus A. Asthma endophenotypes and polymorphisms in the histamine receptor HRH4 gene. International Archives of Allergy and Immunology. 159: 109-20. PMID 22653292 DOI: 10.1159/000335919 | 0.494 | |||
| 2012 | Ungvári I, Hullám G, Antal P, Kiszel PS, Gézsi A, Hadadi É, Virág V, Hajós G, Millinghoffer A, Nagy A, Kiss A, Semsei ÃF, Temesi G, Melegh B, Kisfali P, ... ... Szalai C, et al. Evaluation of a partial genome screening of two asthma susceptibility regions using bayesian network based bayesian multilevel analysis of relevance. Plos One. 7: e33573. PMID 22432035 DOI: 10.1371/Journal.Pone.0033573 | 0.482 | |||
| 2012 | Ungvári I, Hadadi E, Virág V, Bikov A, Nagy A, Semsei AF, Gálffy G, Tamási L, Horváth I, Szalai C. Implication of BIRC5 in asthma pathogenesis. International Immunology. 24: 293-301. PMID 22336533 DOI: 10.1093/Intimm/Dxs007 | 0.52 | |||
| 2012 | Ungvári I, Hadadi E, Virág V, Nagy A, Kiss A, Kalmár A, Zsigmond G, Semsei AF, Falus A, Szalai C. Relationship between air pollution, NFE2L2 gene polymorphisms and childhood asthma in a Hungarian population. Journal of Community Genetics. 3: 25-33. PMID 22207565 DOI: 10.1007/S12687-011-0075-8 | 0.517 | |||
| 2012 | Semsei AF, Erdelyi DJ, Ungvari I, Csagoly E, Hegyi MZ, Kiszel PS, Lautner-Csorba O, Szabolcs J, Masat P, Fekete G, Falus A, Szalai C, Kovacs GT. ABCC1 polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia. Cell Biology International. 36: 79-86. PMID 21929509 DOI: 10.1042/Cbi20110264 | 0.37 | |||
| 2012 | Lautner-Csorba O, Semsei A, Gezsi A, Kutszegi N, Falus A, Szalai C. 1158 Candidate Gene Association Study in Childhood Acute Lymphoblastic Leukemia European Journal of Cancer. 48: S278. DOI: 10.1016/S0959-8049(12)71754-9 | 0.332 | |||
| 2011 | Sherborne AL, Hemminki K, Kumar R, Bartram CR, Stanulla M, Schrappe M, Petridou E, Semsei AF, Szalai C, Sinnett D, Krajinovic M, Healy J, Lanciotti M, Dufour C, Indaco S, et al. Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia. Haematologica. 96: 1049-54. PMID 21459794 DOI: 10.3324/Haematol.2011.040121 | 0.327 | |||
| 2010 | Sherborne AL, Hosking FJ, Prasad RB, Kumar R, Koehler R, Vijayakrishnan J, Papaemmanuil E, Bartram CR, Stanulla M, Schrappe M, Gast A, Dobbins SE, Ma Y, Sheridan E, Taylor M, ... ... Szalai C, et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nature Genetics. 42: 492-4. PMID 20453839 DOI: 10.1038/Ng.585 | 0.314 | |||
| 2010 | Semsei AF, Antal P, Szalai C. Strengths and weaknesses of gene association studies in childhood acute lymphoblastic leukemia. Leukemia Research. 34: 269-71. PMID 19716175 DOI: 10.1016/J.Leukres.2009.07.036 | 0.308 | |||
| 2010 | Szalai C. Genomic background of asthma Lege Artis Medicinae. 20: 835-841. | 0.301 | |||
| 2009 | Tölgyesi G, Molnár V, Semsei AF, Kiszel P, Ungvári I, Pócza P, Wiener Z, Komlósi ZI, Kunos L, Gálffy G, Losonczy G, Seres I, Falus A, Szalai C. Gene expression profiling of experimental asthma reveals a possible role of paraoxonase-1 in the disease. International Immunology. 21: 967-75. PMID 19556304 DOI: 10.1093/Intimm/Dxp063 | 0.789 | |||
| 2008 | Szalai C, Ungvári I, Pelyhe L, Tölgyesi G, Falus A. Asthma from a pharmacogenomic point of view. British Journal of Pharmacology. 153: 1602-14. PMID 18311188 DOI: 10.1038/Bjp.2008.55 | 0.775 | |||
| 2008 | Semsei AF, Erdélyi DJ, Ungvári I, Kámory E, Csókay B, Andrikovics H, Tordai A, Cságoly E, Falus A, Kovács GT, Szalai C. Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia. Leukemia Research. 32: 1214-20. PMID 18243305 DOI: 10.1016/J.Leukres.2007.12.009 | 0.375 | |||
| 2007 | Kiszel P, Kovács M, Szalai C, Yang Y, Pozsonyi E, Blaskó B, Laki J, Prohászka Z, Fazakas A, Pánczél P, Hosszúfalusi N, Rajczy K, Wu YL, Chung EK, Zhou B, et al. Frequency of carriers of 8.1 ancestral haplotype and its fragments in two Caucasian populations. Immunological Investigations. 36: 307-19. PMID 17558713 DOI: 10.1080/08820130701241404 | 0.314 | |||
| 2007 | Ungvári I, Tölgyesi G, Semsei AF, Nagy A, Radosits K, Keszei M, Kozma GT, Falus A, Szalai C. CCR5 Delta 32 mutation, Mycoplasma pneumoniae infection, and asthma. The Journal of Allergy and Clinical Immunology. 119: 1545-7. PMID 17445875 DOI: 10.1016/J.Jaci.2007.02.038 | 0.752 | |||
| 2007 | Nagy A, Keszei M, Kis Z, Budai I, Tölgyesi G, Ungvári I, Falus A, Szalai C. Chlamydophila pneumoniae infection status is dependent on the subtypes of asthma and allergy. Allergy and Asthma Proceedings : the Official Journal of Regional and State Allergy Societies. 28: 58-63. PMID 17390759 DOI: 10.2500/Aap.2007.28.2957 | 0.766 | |||
| 2007 | Laki J, Kiszel P, Vatay A, Blaskó B, Kovács M, Körner A, Madácsy L, Blatniczky L, Almássy Z, Szalai C, Rajczy K, Pozsonyi E, Karádi I, Fazakas A, Hosszúfalusi N, et al. The HLA 8.1 ancestral haplotype is strongly linked to the C allele of -429T>C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotype-independent association of the -429C allele with high hemoglobinA1C levels in diabetic patients. Molecular Immunology. 44: 648-55. PMID 16504296 DOI: 10.1016/J.Molimm.2006.01.011 | 0.339 | |||
| 2006 | Erdélyi DJ, Kámory E, Zalka A, Semsei AF, Csókay B, Andrikovics H, Tordai A, Borgulya G, Magyarosy E, Galántai I, Fekete G, Falus A, Szalai C, Kovács GT. The role of ABC-transporter gene polymorphisms in chemotherapy induced immunosuppression, a retrospective study in childhood acute lymphoblastic leukaemia. Cellular Immunology. 244: 121-4. PMID 17434155 DOI: 10.1016/J.Cellimm.2007.02.007 | 0.336 | |||
| 2006 | Tölgyesi G, Keszei M, Ungvári I, Nagy A, Falus A, Szalai C. Involvement of TNFalpha -308A promoter polymorphism in the development of asthma in children infected with Chlamydophila pneumoniae. Pediatric Research. 60: 543-8. PMID 16988194 DOI: 10.1203/01.Pdr.0000242298.24089.52 | 0.773 | |||
| 2006 | Keszei M, Nagy A, Kozma GT, Radosits K, Tölgyesi G, Falus A, Szalai C. Pediatric asthmatic patients have low serum levels of monocyte chemoattractant protein-1. The Journal of Asthma : Official Journal of the Association For the Care of Asthma. 43: 399-404. PMID 16801146 DOI: 10.1080/02770900600710433 | 0.754 | |||
| 2006 | Szalai C, Tölgyesi G, Nagy A, Falus A. [Pharmacogenomics of asthma: present and perspective]. Orvosi Hetilap. 147: 159-69. PMID 16515024 | 0.783 | |||
| 2006 | Szalai C, Buzás EI, Fülöp AK, Köhidai L, Falus A. Genomic strategies in pharmacology of asthma and autoimmunity Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry. 5: 383-399. DOI: 10.2174/187152306778772847 | 0.386 | |||
| 2006 | Szalai C. Genomic Investigation of Asthma in Human and Animal Models Immunogenomics and Human Disease. 419-441. DOI: 10.1002/0470034092.ch19 | 0.393 | |||
| 2004 | Szalai C, Keszei M, Duba J, Prohászka Z, Kozma GT, Császár A, Balogh S, Almássy Z, Fust G, Czinner A. Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis. 173: 109-14. PMID 15177130 DOI: 10.1016/J.Atherosclerosis.2003.12.003 | 0.683 | |||
| 2003 | Nagy A, Kozma GT, Keszei M, Treszl A, Falus A, Szalai C. The development of asthma in children infected with Chlamydia pneumoniae is dependent on the modifying effect of mannose-binding lectin. The Journal of Allergy and Clinical Immunology. 112: 729-34. PMID 14564351 DOI: 10.1016/S0091-6749(03)02010-4 | 0.749 | |||
| 2003 | Yang Y, Chung EK, Zhou B, Blanchong CA, Yu CY, Füst G, Kovács M, Vatay A, Szalai C, Karádi I, Varga L. Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index. Journal of Immunology (Baltimore, Md. : 1950). 171: 2734-45. PMID 12928427 DOI: 10.4049/Jimmunol.171.5.2734 | 0.317 | |||
| 2003 | Kozma GT, Losonczy G, Keszei M, Komlósi Z, Buzás E, Pállinger E, Appel J, Szabó T, Magyar P, Falus A, Szalai C. Histamine deficiency in gene-targeted mice strongly reduces antigen-induced airway hyper-responsiveness, eosinophilia and allergen-specific IgE. International Immunology. 15: 963-73. PMID 12882834 DOI: 10.1093/Intimm/Dxg095 | 0.686 | |||
| 2003 | Vatay A, Bene L, Kovács A, Prohászka Z, Szalai C, Romics L, Fekete B, Karádi I, Füst G. Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics. 55: 247-52. PMID 12811429 DOI: 10.1007/S00251-003-0575-8 | 0.324 | |||
| 2003 | Vatay A, Yang Y, Chung EK, Zhou Bi, Blanchong CA, Kovács M, Karádi I, Füst G, Romics L L, Varga L, Yu CY, Szalai C. Relationship between complement components C4A and C4B diversities and two TNFA promoter polymorphisms in two healthy Caucasian populations. Human Immunology. 64: 543-52. PMID 12691705 DOI: 10.1016/S0198-8859(03)00036-3 | 0.304 | |||
| 2002 | Nagy A, Kozma GT, Bojszkó A, Krikovszky D, Falus A, Szalai C. No association between asthma or allergy and the CCR5Δ 32 mutation Archives of Disease in Childhood. 86: 426-427. PMID 12023175 DOI: 10.1136/Adc.86.6.426 | 0.524 | |||
| 2002 | Kozma GT, Falus A, Bojszkó A, Krikovszky D, Szabó T, Nagy A, Szalai C. Lack of association between atopic eczema/dermatitis syndrome and polymorphisms in the promoter region of RANTES and regulatory region of MCP-1 Allergy: European Journal of Allergy and Clinical Immunology. 57: 160-163. PMID 11929421 DOI: 10.1034/J.1398-9995.2002.1S3361.X | 0.357 | |||
| 2002 | Szalai C, Füst G, Duba J, Kramer J, Romics L, Prohászka Z, Császár A. Association of polymorphisms and allelic combinations in the tumour necrosis factor-α-complement MHC region with coronary artery disease [3] Journal of Medical Genetics. 39: 46-51. PMID 11826025 DOI: 10.1136/Jmg.39.1.46 | 0.353 | |||
| 2001 | Császár A, Duba J, Melegh B, Kramer J, Szalai C, Prohászka Z, Karádi I, Kovács M, Méhes K, Romics L, Füst G. Increased frequency of the C3*F allele and the Leiden mutation of coagulation factor V in patients with severe coronary heart disease who survived myocardial infarction Experimental and Clinical Immunogenetics. 18: 206-212. PMID 11872951 DOI: 10.1159/000049199 | 0.309 | |||
| 2001 | Szalai C, Kozma GT, Nagy A, Bojszkó A, Krikovszky D, Szabó T, Falus A. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity Journal of Allergy and Clinical Immunology. 108: 375-381. PMID 11544456 DOI: 10.1067/Mai.2001.117930 | 0.534 | |||
| 2001 | Szalai C, Duba J, Prohászka Z, Kalina A, Szabó T, Nagy B, Horváth L, Császár A. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis. 158: 233-9. PMID 11500196 DOI: 10.1016/S0021-9150(01)00423-3 | 0.342 | |||
| 2001 | Kalina A, Császár A, Füst G, Nagy B, Szalai C, Karádi I, Duba J, Prohászka Z, Horváth L, Dieplinger H. The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease. Clinica Chimica Acta; International Journal of Clinical Chemistry. 309: 45-51. PMID 11408005 DOI: 10.1016/S0009-8981(01)00500-9 | 0.312 | |||
| 2000 | Szalai C, Czinner A, Császár A. Influence of apolipoprotein E genotypes on serum lipid parameters in a biracial sample of children European Journal of Pediatrics. 159: 257-260. PMID 10789929 DOI: 10.1007/S004310050065 | 0.354 | |||
| 2000 | Kaczur V, Takács M, Szalai C, Falus A, Nagy Z, Berencsi G, Balázs C. Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease European Journal of Immunogenetics. 27: 17-23. PMID 10651846 DOI: 10.1046/J.1365-2370.2000.00187.X | 0.365 | |||
| 2000 | Szombathy T, Jánoskúti L, Szalai C, Császár A, Miklósi M, Mészáros Z, Kempler P, László Z, Fenyvesi T, Romics L. Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapse syndrome American Heart Journal. 139: 101-105. PMID 10618569 DOI: 10.1016/S0002-8703(00)90315-6 | 0.361 | |||
| 1999 | Szalai C, Császár A, Czinner A, Szabó T, Pánczél P, Madácsy L, Falus A. Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin- dependent diabetes mellitus Pediatric Research. 46: 82-84. PMID 10400139 DOI: 10.1203/00006450-199907000-00014 | 0.368 | |||
| 1998 | Derfalvi B, Nemet K, Szalai C, Kenesei E, Sallay P, Tulassay T, Falus A. In vitro effect of human recombinant growth hormone on lymphocyte and granulocyte function of healthy and uremic children Immunology Letters. 63: 41-47. PMID 9719437 DOI: 10.1016/S0165-2478(98)00052-2 | 0.323 | |||
| 1998 | Szombathy T, Szalai C, Katalin B, Palicz T, László Romics, Császár A. Association of angiotensin II type 1 receptor polymorphism with resistant essential hypertension Clinica Chimica Acta. 269: 91-100. PMID 9498106 DOI: 10.1016/S0009-8981(97)00184-8 | 0.314 | |||
| 1997 | Szalai C, Császár A, Czinner A, Bihari-Varga M, Romics L. Apolipoprotein A-IV and E polymorphisms in children with IDDM Diabetes Care. 20: 1926-1927. PMID 9405926 DOI: 10.2337/Diacare.20.12.1926 | 0.308 | |||
| 1997 | Csaszar A, Halmos B, Palicz T, Szalai C, Romics L. Interpopulation effect of ACE I/D polymorphism on serum concentration of ACE in diagnosis of sarcoidosis [10] Lancet. 350: 518. PMID 9274601 DOI: 10.1016/S0140-6736(05)63108-X | 0.338 | |||
| 1997 | Császár A, Kálmán J, Szalai C, Janka Z, Romics L. Association of the apolipoprotein A-IV codon 360 mutation in patients with Alzheimer's disease Neuroscience Letters. 230: 151-154. PMID 9272683 DOI: 10.1016/S0304-3940(97)00500-4 | 0.313 | |||
| Low-probability matches (unlikely to be authored by this person) | |||||
| 2007 | Kovacs G, Erdelyi D, Semsei A, Kamory E, Csoka M, Tordai A, Szalai C. O02 The effects of transporter gene polymorphisms on the immunosuppressive effects of chemotherapy in childhood acute lymphoblastic leukemia (ALL) Blood Reviews. 21: S67. DOI: 10.1016/S0268-960X(07)70020-6 | 0.296 | |||
| 2016 | Sági JC, Kutszegi N, Kelemen A, Fodor LE, Gézsi A, Kovács GT, Erdélyi DJ, Szalai C, Semsei ÁF. Pharmacogenetics of anthracyclines. Pharmacogenomics. PMID 27266419 DOI: 10.2217/Pgs-2016-0036 | 0.291 | |||
| 2004 | Bors A, Andrikovics H, Kalmár L, Erdei N, Galambos S, Losonczi A, Füredi S, Balogh I, Szalai C, Tordai A. Frequencies of two common mutations (c.35delG and c.167delT) of the connexin 26 gene in different populations of Hungary. International Journal of Molecular Medicine. 14: 1105-8. PMID 15547683 DOI: 10.3892/Ijmm.14.6.1105 | 0.29 | |||
| 2018 | Sági JC, Egyed B, Kelemen A, Kutszegi N, Hegyi M, Gézsi A, Herlitschke MA, Rzepiel A, Fodor LE, Ottóffy G, Kovács GT, Erdélyi DJ, Szalai C, Semsei ÁF. Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma. Bmc Cancer. 18: 704. PMID 29970035 DOI: 10.1186/S12885-018-4629-6 | 0.286 | |||
| 2000 | Derfalvi B, Igaz P, Fulop KA, Szalai C, Falus A. Interleukin-6-induced production of type II acute phase proteins and expression of junB gene are downregulated by human recombinant growth hormone in vitro Cell Biology International. 24: 109-114. PMID 10772770 DOI: 10.1006/Cbir.1999.0454 | 0.286 | |||
| 2004 | Füst G, Arason GJ, Kramer J, Szalai C, Duba J, Yang Y, Chung EK, Zhou B, Blanchong CA, Lokki ML, Bödvarsson S, Prohászka Z, Karádi I, Vatay A, Kovács M, et al. Genetic basis of tobacco smoking: strong association of a specific major histocompatibility complex haplotype on chromosome 6 with smoking behavior. International Immunology. 16: 1507-14. PMID 15339882 DOI: 10.1093/Intimm/Dxh152 | 0.284 | |||
| 2017 | Molnár V, Nagy A, Tamási L, Gálffy G, Böcskei R, Bikov A, Czaller I, Csoma Z, Krasznai M, Csáki C, Zsigmond G, Csontos Z, Kurucz A, Kurucz E, Fábos B, ... ... Szalai C, et al. From genomes to diaries: a 3-year prospective, real-life study of ragweed-specific sublingual immunotherapy. Immunotherapy. 9: 1279-1294. PMID 29130793 DOI: 10.2217/Imt-2017-0093 | 0.284 | |||
| 1997 | Szalai C, Triga D, Czinner A. Novel Mutations in the Vasopressin V2 Receptor Gene in Hungarian Children With Nephrogenic Diabetes Insipidus Pediatric Research. 42: 408-408. DOI: 10.1203/00006450-199709000-00159 | 0.283 | |||
| 2020 | Gál Z, Gézsi A, Pállinger É, Visnovitz T, Nagy A, Kiss A, Sultész M, Csoma Z, Tamási L, Gálffy G, Szalai C. Author Correction: Plasma neutrophil extracellular trap level is modified by disease severity and inhaled corticosteroids in chronic inflammatory lung diseases. Scientific Reports. 10: 13182. PMID 32737369 DOI: 10.1038/S41598-020-69873-4 | 0.282 | |||
| 2002 | Igaz P, Fitzimons CP, Szalai C, Falus A. Histamine genomics in silico: polymorphisms of the human genes involved in the synthesis, action and degradation of histamine. American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice. 2: 67-72. PMID 12083955 DOI: 10.2165/00129785-200202010-00006 | 0.281 | |||
| 2000 | Szalai C, Bojszko A, Beko G, Falus A. Prevalence of CCR5Δ32 in allergic diseases Lancet. 355: 66. PMID 10615909 DOI: 10.1016/S0140-6736(05)72005-5 | 0.276 | |||
| 1998 | Igaz P, Fejér G, Szalai C, Tóth S, Falus A. Development of competitive mRNA PCR for the quantification of interleukin-6-responsive junB oncogene expression Biotechniques. 24: 854-860. PMID 9591138 DOI: 10.2144/98245Rr02 | 0.276 | |||
| 1998 | Szalai C, Triga D, Czinner A. C112R, W323S, N317K mutations in the vasopressin V2 receptor gene in patients with nephrogenic diabetes insipidus. Mutations in brief no. 165. Online Human Mutation. 12: 137-138. PMID 10694923 DOI: 10.1002/(Sici)1098-1004(1998)12:2<137::Aid-Humu16>3.0.Co;2-J | 0.273 | |||
| 2010 | Szabó PM, Tamási V, Molnár V, Andrásfalvy M, Tömböl Z, Farkas R, Kövesdi K, Patócs A, Tóth M, Szalai C, Falus A, Rácz K, Igaz P. Meta-analysis of adrenocortical tumour genomics data: novel pathogenic pathways revealed. Oncogene. 29: 3163-72. PMID 20305693 DOI: 10.1038/Onc.2010.80 | 0.273 | |||
| 2002 | Hunter M, Heyer E, Austerlitz F, Angelicheva D, Nedkova V, Briones P, Gata A, de Pablo R, László A, Bosshard N, Gitzelmann R, Tordai A, Kalmar L, Szalai C, Balogh I, et al. The P28T mutation in the GALK1 gene accounts for galactokinase deficiency in Roma (Gypsy) patients across Europe. Pediatric Research. 51: 602-6. PMID 11978884 DOI: 10.1203/00006450-200205000-00010 | 0.268 | |||
| 2001 | Kalina A, Császár A, Czeizel AE, Romics L, Szabóki F, Szalai C, Reiber I, Németh A, Stephenson S, Williams RR. Frequency of the R3500Q mutation of the apolipoprotein B-100 gene in a sample screened clinically for familial hypercholesterolemia in Hungary. Atherosclerosis. 154: 247-51. PMID 11137107 DOI: 10.1016/S0021-9150(00)00648-1 | 0.265 | |||
| 2014 | Jobbágy-Óvári G, Páska C, Stiedl P, Trimmel B, Hontvári D, Soós B, Hermann P, Tóth Z, Kerekes-Máthé B, Nagy D, Szántó I, Nagy Ã, Martonosi M, Nagy K, Hadadi É, ... Szalai C, et al. Complex analysis of multiple single nucleotide polymorphisms as putative risk factors of tooth agenesis in the Hungarian population. Acta Odontologica Scandinavica. 72: 216-27. PMID 23964635 DOI: 10.3109/00016357.2013.822547 | 0.265 | |||
| 2008 | Erdilyi DJ, Kámory E, Csókay B, Andrikovics H, Tordai A, Kiss C, Filni-Semsei A, Janszky I, Zalka A, Fekete G, Falus A, Kovács GT, Szalai C. Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy Pharmacogenomics Journal. 8: 321-327. PMID 17938643 DOI: 10.1038/sj.tpj.6500480 | 0.262 | |||
| 1998 | Derfalvi B, Szalai C, Mandi Y, Kiraly A, Falus A. Growth hormone receptor gene expression on human lymphocytic and monocytic cell lines Cell Biology International. 22: 849-853. PMID 10873296 DOI: 10.1006/Cbir.1998.0324 | 0.26 | |||
| 2019 | Rzepiel A, Kutszegi N, Egyed B, Gézsi A, Csányi JS, Semsei ÁF, Szalai C, Erdélyi DJ. Circulating microRNAs as Potential Minimal Residual Disease Biomarkers in Pediatric Acute Lymphoblastic Leukemia Clinical Lymphoma Myeloma and Leukemia. 19: S193. DOI: 10.1016/J.Clml.2019.07.039 | 0.26 | |||
| 2003 | Kaczur V, Puskás LG, Takács M, Rácz IA, Szendroi A, Tóth S, Nagy Z, Szalai C, Balázs C, Falus A, Knudsen B, Farid NR. Evolution of the thyrotropin receptor: a G protein coupled receptor with an intrinsic capacity to dimerize. Molecular Genetics and Metabolism. 78: 275-90. PMID 12706379 DOI: 10.1016/S1096-7192(03)00036-2 | 0.259 | |||
| 2000 | Szalai C, Tóth S, Falus A. Exon-intron organization of the human gp130 gene Gene. 243: 161-166. PMID 10675624 DOI: 10.1016/S0378-1119(99)00536-3 | 0.258 | |||
| 1998 | Bencsáth M, Pálóczi K, Szalai C, Szenthe A, Szeberényi J, Falus A. Histidine decarboxylase in peripheral lymphocytes of healthy individuals and chronic lymphoid leukemia patients possible involvement of intracellular histamine in the regulation of lymphocyte proliferation Pathology and Oncology Research. 4: 121-124. PMID 9654597 DOI: 10.1007/Bf02904705 | 0.254 | |||
| 2020 | Egyed B, Kutszegi N, Sági JC, Gézsi A, Rzepiel A, Visnovitz T, Lőrincz P, Müller J, Zombori M, Szalai C, Erdélyi DJ, Kovács GT, Semsei ÁF. MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia. Journal of Translational Medicine. 18: 250. PMID 32571344 DOI: 10.1186/S12967-020-02415-8 | 0.251 | |||
| 2002 | Kalina A, Szalai C, Prohászka Z, Reiber I, Császár A. Association of plasma lipid levels with apolipoprotein E polymorphism in Type 2 diabetes. Diabetes Research and Clinical Practice. 56: 63-8. PMID 11879722 DOI: 10.1016/S0168-8227(01)00350-3 | 0.251 | |||
| 1999 | Horváth BV, Szalai C, Mándi Y, László V, Radvány Z, Darvas Z, Falus A. Histamine and histamine-receptor antagonists modify gene expression and biosynthesis of interferon γ in peripheral human blood mononuclear cells and in CD19-depleted cell subsets Immunology Letters. 70: 95-99. PMID 10569698 DOI: 10.1016/S0165-2478(99)00126-1 | 0.251 | |||
| 2019 | Egyed B, Sági JC, Kutszegi N, Gézsi A, Rzepiel A, Szalai C, Kovács GT, Erdélyi DJ, Semsei ÁF. New Liquid Biopsy Markers for the Detection of Central Nervous System Involvement in Childhood Acute Leukemia Clinical Lymphoma Myeloma and Leukemia. 19: S187-S188. DOI: 10.1016/J.Clml.2019.07.028 | 0.249 | |||
| 2001 | Fulop AK, Pocsik E, Brozik M, Karabelyos C, Kiss A, Novak I, Szalai C, Dobozy O, Falus A. Hepatic regeneration induces transient acute phase reaction: Systemic elevation of acute phase reactants and soluble cytokine receptors Cell Biology International. 25: 585-592. PMID 11448096 DOI: 10.1006/Cbir.2000.0715 | 0.249 | |||
| 1998 | Szalai C, Császár A, Czinner A, Szabó T, Falus A. High frequency of the CCR5 deletion allele in Gypsies living in Hungary Immunology Letters. 63: 57-58. PMID 9719440 DOI: 10.1016/S0165-2478(98)00048-0 | 0.247 | |||
| 2002 | Pap E, Rácz K, Kovács JK, Varga I, Buzás E, Madarász B, Földes C, Szalai C, Watanabe T, Ohtsu H, Ichikawa A, Nagy A, Falus A. Histidine decarboxylase deficiency in gene knockout mice elevates male sex steroid production. The Journal of Endocrinology. 175: 193-9. PMID 12379503 DOI: 10.1677/Joe.0.1750193 | 0.241 | |||
| 2019 | Sagi JC, Artner A, Kelemen A, Egyed B, Rzepiel A, Kutszegi N, Gezsi A, Kovács GT, Szalai C, Erdelyi DJ, Semsei AF. Pharmacogenetic Study of the Central Nervous System in Pediatric Acute Lymphoblastic Leukemia Clinical Lymphoma Myeloma and Leukemia. 19: S189-S190. DOI: 10.1016/J.Clml.2019.07.032 | 0.239 | |||
| 2000 | Haak-Frendscho M, Darvas Z, Hegyesi H, Kárpáti S, Hoffman RL, László V, Bencsáth M, Szalai C, Fürész J, Timár J, Bata-Csörgõ Z, Szabad G, Pivarcsi A, Pállinger E, Kemény L, et al. Histidine decarboxylase expression in human melanoma Journal of Investigative Dermatology. 115: 345-352. PMID 10951267 DOI: 10.1046/J.1523-1747.2000.00054.X | 0.238 | |||
| 2002 | Vatay A, Rajczy K, Pozsonyi E, Hosszúfalusi N, Prohászka Z, Füst G, Karádi I, Szalai C, Grósz A, Bártfai Z, Pánczél P. Differences in the genetic background of latent autoimmune diabetes in adults (LADA) and type 1 diabetes mellitus. Immunology Letters. 84: 109-115. PMID 12270547 DOI: 10.1016/S0165-2478(02)00156-6 | 0.237 | |||
| 2001 | Varga VL, Fülöp AK, Holub MC, Tóth S, Szalai C, Falus A. gp130-specific antisense oligonucleotides inhibit IL-6 signal inducing junB mRNA transcription in the human hepatoma cell line, HepG2. Cell Biology International. 25: 835-40. PMID 11482910 DOI: 10.1006/Cbir.2001.0765 | 0.235 | |||
| 1999 | Karabélyos C, Dobozy O, Szalai C, Klenjánszki K, Varjú K, Hadházi A, Kiss A, Fülöp AK, Madarász B, Falus A. Elevated hepatic glucocorticoid receptor expression during liver regeneration in rats Pathology and Oncology Research. 5: 107-109. PMID 10393361 DOI: 10.1053/Paor.1999.0168 | 0.234 | |||
| 2019 | Rzepiel A, Kutszegi N, Gézsi A, Sági JC, Egyed B, Péter G, Butz H, Nyírő G, Müller J, Kovács GT, Szalai C, Semsei ÁF, Erdélyi DJ. Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia. Journal of Translational Medicine. 17: 372. PMID 31727091 DOI: 10.1186/S12967-019-2114-X | 0.231 | |||
| 2002 | Wiener Z, Andrásfalvy M, Pállinger E, Kovács P, Szalai C, Erdei A, Tóth S, Nagy A, Falus A. Bone marrow-derived mast cell differentiation is strongly reduced in histidine decarboxylase knockout, histamine-free mice. International Immunology. 14: 381-7. PMID 11934874 DOI: 10.1093/Intimm/14.4.381 | 0.231 | |||
| 2000 | Molnár EL, Hegyesi H, Tóth S, Darvas Z, László V, Szalai C, Falus A. Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine. Seminars in Cancer Biology. 10: 25-8. PMID 10888268 DOI: 10.1006/Scbi.2000.0304 | 0.23 | |||
| 2000 | Radvány Z, Darvas Z, Kerekes K, Prechl J, Szalai C, Pállinger E, Valéria L, Varga VL, Sandor M, Erdei A, Falus A. H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells. Seminars in Cancer Biology. 10: 41-5. PMID 10888270 DOI: 10.1006/Scbi.2000.0306 | 0.23 | |||
| 1999 | Csilla Holub M, Szalai C, Polgár A, Tóth S, Falus A. Generation of 'truncated' interleukin-6 receptor (IL-6R) mRNA by alternative splicing; a possible source of soluble IL-6R Immunology Letters. 68: 121-124. PMID 10397166 DOI: 10.1016/S0165-2478(99)00040-1 | 0.23 | |||
| 2010 | Csorba O, Semsei A, Erdélyi D, Barabás E, Vángor M, Schermann G, Hadadi E, Virág V, Falus A, Szalai C. 68 Examination of GST and CCR5 gene polymorphisms in children with acute lymphoid leukemia in Hungarian population European Journal of Cancer Supplements. 8: 18. DOI: 10.1016/S1359-6349(10)70877-6 | 0.229 | |||
| 2015 | Gézsi A, Bolgár B, Marx P, Sarkozy P, Szalai C, Antal P. VariantMetaCaller: automated fusion of variant calling pipelines for quantitative, precision-based filtering. Bmc Genomics. 16: 875. PMID 26510841 DOI: 10.1186/S12864-015-2050-Y | 0.228 | |||
| 2007 | Füst G, Sasvári M, Blaskó B, Szalai C, Ádány R, Yu C, Arason GJ. Imbalance of the C4A and C4B genes dosage as a robust risk factor for premature cardiovascular disease morbidity and mortality Molecular Immunology. 44: 173. DOI: 10.1016/J.Molimm.2006.07.064 | 0.224 | |||
| 2014 | Temesi G, Bolgár B, Arany A, Szalai C, Antal P, Mátyus P. Early repositioning through compound set enrichment analysis: a knowledge-recycling strategy. Future Medicinal Chemistry. 6: 563-75. PMID 24649958 DOI: 10.4155/Fmc.14.4 | 0.224 | |||
| 2012 | Semsei A, Lautner-Csorba O, Schermann G, Kutszegi N, Falus A, Kovacs G, Szalai C, Erdelyi D. 980 Genetic Risk Factors of Neurotoxicity During Chemotherapy European Journal of Cancer. 48: S236. DOI: 10.1016/S0959-8049(12)71598-8 | 0.222 | |||
| 1998 | Igaz P, Tóth S, Rose-John S, Madurka I, Fejér G, Szalai C, Falus A. Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes Cytokine. 10: 620-626. PMID 9722935 DOI: 10.1006/Cyto.1997.0330 | 0.221 | |||
| 1998 | Szalai C, Czinner A, Csaszar A, Szabo T, Falus A. Frequency of the HIV-1 resistance CCR5 deletion allele in Hungarian newborns [4] European Journal of Pediatrics. 157: 782. PMID 9776544 DOI: 10.1007/S004310050936 | 0.219 | |||
| 1997 | Kaczur V, Szalai C, Falus A, Nagy Z, Krajczár G, Balázs C. Polymorphism of the 52 triplet gene (nucleotide 253) of the TSH receptor in Basedow-Graves patients and in healthy controls Orvosi Hetilap. 138: 1625-1628. PMID 9265143 | 0.219 | |||
| 2000 | Igaz P, Horváth A, Horváth B, Szalai C, Pállinger E, Rajnavölgyi E, Tóth S, Rose-John S, Falus A. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production Immunology Letters. 71: 143-148. PMID 10722865 DOI: 10.1016/S0165-2478(00)00157-7 | 0.213 | |||
| 2002 | Szalai C, Kozma GT, Nagy A, Bojszkó A, Falus A. [Genomic approach to allergic diseases: present and future perspectives]. Orvosi Hetilap. 143: 381-90. PMID 11921704 | 0.212 | |||
| 2001 | Bauer K, Janitz M, Reiners-Schramm L, Muhlethaler-Mottet A, Rosowski M, Lauster R, Agnholt J, Kaltoft K, Eriksen KW, Nielsen M, Kaltoft K, Svejgaard A, Nissen MH, Röpke C, Ødum N, ... ... Szalai C, et al. Subject Index Vol. 18, 2001 Experimental and Clinical Immunogenetics. 18: 281-281. DOI: 10.1159/000049206 | 0.206 | |||
| 2021 | Sági JC, Gézsi A, Egyed B, Jakab Z, Benedek N, Attarbaschi A, Köhrer S, Sipek J, Winkowska L, Zaliova M, Anastasopoulou S, Wolthers BO, Ranta S, Szalai C, Kovács GT, et al. Pharmacogenetics of the Central Nervous System-Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia. Cancers. 13. PMID 34066083 DOI: 10.3390/cancers13102333 | 0.205 | |||
| 1998 | Dérfalvi B, Sallai P, Német K, Szalai C, Kenesei E, Tulassay T, Falus A. The in vitro effect of recombinant human growth hormone on lymphocyte and granulocyte function in healthy and uremic children Orvosi Hetilap. 139: 1847-1850. PMID 9729679 | 0.175 | |||
| 2009 | Hegyi Z, Semsei A, Cságoly E, Bácsi K, Erdélyi D, Szalai C, Kovacs G. 4114 Influence of the GGH −401C>T and the RFC1 A(80)G polymorphism on methotrexate toxicity in children with osteosarcoma European Journal of Cancer Supplements. 7: 224. DOI: 10.1016/S1359-6349(09)70767-0 | 0.175 | |||
| 2010 | Hegyi M, Semsei A, Csagoly E, Erdelyi D, Szalai C, Kovács G. 261 Clinical importance of GGH −401C>T and the RFC1 A(80)G polymorphism in children with osteosarcoma European Journal of Cancer Supplements. 8: 68. DOI: 10.1016/S1359-6349(10)71066-1 | 0.169 | |||
| 2020 | Gál Z, Gézsi A, Semsei ÁF, Nagy A, Sultész M, Csoma Z, Tamási L, Gálffy G, Szalai C. Investigation of circulating lncRNAs as potential biomarkers in chronic respiratory diseases. Journal of Translational Medicine. 18: 422. PMID 33168013 DOI: 10.1186/s12967-020-02581-9 | 0.157 | |||
| 1998 | Holub MC, Makó E, Dévay T, Dank M, Szalai C, Fenyvesi A, Falus A. Increased interleukin-6 levels, interleukin-6 receptor and gp130 expression in peripheral lymphocytes of patients with inflammatory bowel disease Scandinavian Journal of Gastroenterology, Supplement. 33: 47-50. PMID 9867112 | 0.154 | |||
| 2020 | Kutszegi N, Gézsi A, Semsei ÁF, Müller J, Simon R, Kovács ER, Hegedüs K, Kovács GT, Szalai C, Erdélyi DJ. Two tagging SNPs to capture HLA-DRB1*07:01-DQA1*02:01-DQB1*02:02 haplotype associated with asparaginase hypersensitivity. British Journal of Clinical Pharmacology. PMID 33217039 DOI: 10.1111/bcp.14664 | 0.15 | |||
| 2001 | Bauer K, Janitz M, Reiners-Schramm L, Muhlethaler-Mottet A, Rosowski M, Lauster R, Agnholt J, Kaltoft K, Eriksen KW, Nielsen M, Kaltoft K, Svejgaard A, Nissen MH, Röpke C, Ødum N, ... ... Szalai C, et al. Contents Vol. 18, 2001 Experimental and Clinical Immunogenetics. 18: 282-282. DOI: 10.1159/000049207 | 0.15 | |||
| 2015 | Szalai C. Genomic approach to complex diseases Ifmbe Proceedings. 50: 1-6. DOI: 10.1007/978-981-287-573-0_1 | 0.146 | |||
| 2021 | Truderung OA, Sagi JC, Semsei AF, Szalai C. Melanoma susceptibility: an update on genetic and epigenetic findings. International Journal of Molecular Epidemiology and Genetics. 12: 71-89. PMID 34853632 | 0.142 | |||
| 1998 | Szalai C, Molnár E, Sallay P, Czinner A. [Molecular biological studies on patients with nephrogenic diabetes insipidus]. Orvosi Hetilap. 139: 883-7. PMID 9579101 | 0.142 | |||
| 1999 | Szalai S, Szalai C, Becker K, Török E. Keratin 9 mutations in the coil 1A region in epidermolytic palmoplantar keratoderma Pediatric Dermatology. 16: 430-435. PMID 10632938 DOI: 10.1046/j.1525-1470.1999.00111.x | 0.133 | |||
| 1995 | Szalai C, Czinner A, Révai K, Nagy I. [Screening of newborn infants for medium-chain acyl-CoA dehydrogenase deficiency in Hungary]. Orvosi Hetilap. 136: 1595-8. PMID 7637977 | 0.125 | |||
| 2000 | Hegyesi H, Szalai C, Falus A, Csaba G. The histidine decarboxylase (HDC) gene of Tetrahymena pyriformis is similar to the mammalian one. A study of HDC expression. Bioscience Reports. 19: 73-9. PMID 10888469 DOI: 10.1023/A:1020102308791 | 0.124 | |||
| 1997 | Radvany Z, Darvas Z, Szalai C, Falus A. Anti-CD3 antibody induces histidine-decarboxylase gene expression in human lymphocytes Medical Science Monitor. 3: 619-623. | 0.12 | |||
| 1998 | Kalina A, Czeizel E, Romics L, Pados G, Reiber I, Dósa A, Hermányi I, Lakatos Z, Tarján J, Kollega-Tarsoly E, Kovács M, Szalai C, Császár A. Incidence of familial defective apolipoprotein B-100 in cases of patients diagnosed with familial hypercholesterolemia Orvosi Hetilap. 139: 755-759. PMID 9578704 | 0.12 | |||
| 2023 | Szalai C. Arguments for and against the whole-genome sequencing of newborns. American Journal of Translational Research. 15: 6255-6263. PMID 37969196 | 0.119 | |||
| 2011 | Russo P, Nastrucci C, Alzetta G, Szalai C. Tobacco Habit: Historical, cultural, neurobiological, and genetic features of people's relationship with an addictive drug Perspectives in Biology and Medicine. 54: 557-577. PMID 22019540 DOI: 10.1353/pbm.2011.0047 | 0.116 | |||
| 1999 | Szalai C, Csaszar A, Czinner A, Palicz T, Halmos B, Romics L. Genetic investigation of patients with hypercholesterolemia type IIa [4] Clinical Genetics. 55: 67-68. PMID 10066037 DOI: 10.1034/j.1399-0004.1999.550114.x | 0.11 | |||
| 2022 | Egyed B, Horváth A, Semsei ÁF, Szalai C, Müller J, Erdélyi DJ, Kovács GT. Co-Detection of VEGF-A and Its Regulator, microRNA-181a, May Indicate Central Nervous System Involvement in Pediatric Leukemia. Pathology Oncology Research : Por. 28: 1610096. PMID 35449729 DOI: 10.3389/pore.2022.1610096 | 0.097 | |||
| 1996 | Szalai C, Czinner A, Revai K. The frequency of medium-chain acyl-CoA dehydrogenase G985 mutation in the Hungarian population [4] European Journal of Pediatrics. 155: 256. PMID 8929741 | 0.083 | |||
| 2011 | Hegyi M, Gulacsi A, Semsei A, Cságoly E, Erdelyi D, Szalai C, Kovacs G. 4111 POSTER Clinical Importance of Methotrexate Pharmacokinetics and Pharmacogenetics in Pediatric Osteosarcoma European Journal of Cancer. 47: S287. DOI: 10.1016/S0959-8049(11)71289-8 | 0.069 | |||
| 2017 | Sárközy P, Molnár V, Fogl D, Szalai C, Antal P. Beyond Homopolymer Errors: a Systematic Investigation of Nanopore-based DNA Sequencing Characteristics Using HLA-DQA2 Periodica Polytechnica Electrical Engineering and Computer Science. 61: 231. DOI: 10.3311/PPEE.10015 | 0.069 | |||
| 2023 | Rzepiel A, Horváth A, Kutszegi N, Gézsi A, Sági JC, Almási L, Egyed B, Lőrincz P, Visnovitz T, Kovács GT, Szalai C, Semsei ÁF, Erdélyi DJ. MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia. Molecular and Cellular Probes. 67: 101893. PMID 36640912 DOI: 10.1016/j.mcp.2023.101893 | 0.062 | |||
| 2013 | Singer S, Szalai C, Briest S, Brown A, Dietz A, Einenkel J, Jonas S, Konnopka A, Papsdorf K, Langanke D, Löbner M, Schiefke F, Stolzenburg JU, Weimann A, Wirtz H, et al. Co-morbid mental health conditions in cancer patients at working age - Prevalence, risk profiles, and care uptake Psycho-Oncology. 22: 2291-2297. PMID 23494948 DOI: 10.1002/pon.3282 | 0.05 | |||
| 2010 | Cassell AM, Beck RAS, Arnold JO, Hwang H, Wright MJ, Szalai CE, Blosser M, Poteet CC. Development of thermal protection materials for future mars entry, descent and landing systems 10th Aiaa/Asme Joint Thermophysics and Heat Transfer Conference. | 0.044 | |||
| 2002 | Falus A, Szalai C, Tóth S. Functional genomics: Potentials, hopes and post-genomic realism Lege Artis Medicinae. 12: 365-370. | 0.043 | |||
| 2011 | Szalai CE, Thoma BL, Lee WJ, Maki JN, Willcockson WH, Venkatapathy E, White TR. Mars exploration rover heatshield observation campaign 42nd Aiaa Thermophysics Conference. | 0.042 | |||
| 2011 | Szalai CE, Beck RAS, Gasch MJ, Alunni AI, Chavez-Garcia JF, Splinter SC, Gragg JG, Brewer A. Thermal protection system aerothermal screening tests in the HYMETS facility 42nd Aiaa Thermophysics Conference. | 0.037 | |||
| 2014 | Mehnert A, Brähler E, Faller H, Härter M, Keller M, Schulz H, Wegscheider K, Weis J, Boehncke A, Hund B, Reuter K, Richard M, Sehner S, Sommerfeldt S, Szalai C, et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 3540-6. PMID 25287821 DOI: 10.1200/JCO.2014.56.0086 | 0.031 | |||
| 2003 | Szalai C, Chen YK, Loomis M, Hui F, Thoma B, Buck S, Scrivens L. Mars exploration rover tirs cover thermal protection system design verification 36th Aiaa Thermophysics Conference. | 0.029 | |||
| 2005 | Szalai C, Chen YK, Loomis M, Thoma B, Buck S. Mars Exploration Rover transverse impulse rocket cover thermal protection system design verification Journal of Spacecraft and Rockets. 42: 990-998. DOI: 10.2514/1.3637 | 0.028 | |||
| 2015 | Faller H, Koch U, Brähler E, Härter M, Keller M, Schulz H, Wegscheider K, Weis J, Boehncke A, Hund B, Reuter K, Richard M, Sehner S, Szalai C, Wittchen HU, et al. Satisfaction with information and unmet information needs in men and women with cancer. Journal of Cancer Survivorship : Research and Practice. PMID 25956402 DOI: 10.1007/s11764-015-0451-1 | 0.028 | |||
| 2016 | Faller H, Weis J, Koch U, Brähler E, Härter M, Keller M, Schulz H, Wegscheider K, Boehncke A, Hund B, Reuter K, Richard M, Sehner S, Szalai C, Wittchen HU, et al. Perceived need for psychosocial support depending on emotional distress and mental comorbidity in men and women with cancer. Journal of Psychosomatic Research. 81: 24-30. PMID 26800635 DOI: 10.1016/j.jpsychores.2015.12.004 | 0.024 | |||
| 2002 | Parmenter KE, Shuman K, Milstein F, Szalai CE, Tran HK, Rasky DJ. Compressive response of lightweight ceramic ablators: Silicone impregnated reusable ceramic ablator Journal of Spacecraft and Rockets. 39: 290-298. | 0.013 | |||
| 2014 | Szalai C, Slimko E, Hoffman P. Mars science laboratory heatshield development, implementation, and lessons learned Journal of Spacecraft and Rockets. 51: 1167-1173. DOI: 10.2514/1.A32673 | 0.01 | |||
| 2012 | Feldman JD, Gasch MJ, Poteet CC, Szalai CE. Advanced rigid ablative thermal protection systems 50th Aiaa Aerospace Sciences Meeting Including the New Horizons Forum and Aerospace Exposition. DOI: 10.2514/6.2012-472 | 0.01 | |||
| 2011 | Slimko E, Szalai C, Hoffman P. MSL heatshield development: From failure to success Ieee Aerospace Conference Proceedings. DOI: 10.1109/AERO.2011.5747500 | 0.01 | |||
| 2001 | Parmenter KE, Shuman K, Milstein F, Szalai CE, Tran HK, Rasky DJ. Compressive response of lightweight ceramic ablators: Phenolic impregnated carbon ablator Journal of Spacecraft and Rockets. 38: 231-236. | 0.01 | |||
| Hide low-probability matches. | |||||